Company News in the Life Science Industry

»

Reset 

Acutus Medical Announces Pricing of Initial Public Offering

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  Acutus Medical, Inc.

Dornier MedTech Launches UroX, a new community to boost innovation in the field of urology

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  Advanced MedTech Holdings Pte. Ltd.

Idorsia Japan confirms daridorexant dose response in Japanese patients with insomnia – preparation for a local registration program advancing

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  Idorsia Pharmaceuticals Ltd

Fagron turnover up 9.1%; REBITDA increased 13.2% to € 62.9 million

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  Fagron BV

Hyloris Reports Half-Year 2020 Financial Results and Business Highlights

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  Hyloris Pharmaceuticals SA

ObsEva Announces Second Quarter 2020 Financial Results and Business Update

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  ObsEva SA

Valneva Announces Appointment of Juan Carlos Jaramillo as Chief Medical Officer

Read more ››
By: GlobenewsWire - 06 Aug 2020

Addex Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2020

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  Addex Therapeutics

Braskem S.A.: EBITDA reached US$310 million, increasing 5% from 1Q20

SÃO PAULO, Aug. 5, 2020 /PRNewswire/ -- BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) announces today its results for 2Q20.

Read more ››
By: PR Newswire Association LLC. - 06 Aug 2020

FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure

RADNOR, Pa. and GENEVA, Aug. 6, 2020 /PRNewswire/ -- NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF, OTC:RLFTF) "Relief" today announced that NeuroRx has been granted Investigational New Drug (IND) permission to test RLF-100 (aviptadil) for inhaled use in patients with moderate and... Read more ››

By: PR Newswire Association LLC. - 06 Aug 2020

Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million

CRANFORD, N.J., Aug. 5, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that, due to demand, the underwriter has agreed to increase... Read more ››

By: PR Newswire Association LLC. - 06 Aug 2020
Related companies:  Citius Pharmaceuticals, Inc.

FDA issues Emergency Use Authorization to Vela Diagnostics' coronavirus PCR test

FAIRFIELD, N.J., Aug. 5, 2020 /CNW/ -- Vela Diagnostics announced that the manual version of its coronavirus PCR test has obtained Emergency Use Authorization from the U.S. Food and Drug Administration (FDA). By targeting conserved regions of the viral genome, the probe-based reverse transcription... Read more ››

By: PR Newswire Association LLC. - 06 Aug 2020
Related companies:  VELA DIAGNOSTICS USA INC

Flotek Announces Second Quarter 2020 Earnings Results

HOUSTON, Aug. 5, 2020 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced results for the three months and full year ended June 30, 2020. As a result of the Company's recent acquisition of JP3 in May, Flotek is presenting its results as two reported... Read more ››

By: PR Newswire Association LLC. - 06 Aug 2020

Zenabis Global Inc. Adopts Advance Notice Policy

VANCOUVER, BC, Aug. 5, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis") is pleased to announce that Zenabis' board of directors (the "Board") has adopted a new policy that requires advance notice to Zenabis for nominations of directors other than by management, through... Read more ››

By: PR Newswire Association LLC. - 06 Aug 2020

BioAegis Therapeutics Initiates Phase 2 Clinical Trial of Its Inflammation Regulator, Gelsolin, for COVID-19 Treatment

Read more ››
By: GlobenewsWire - 06 Aug 2020
Related companies:  BioAegis Therapeutics Inc.

Assure to Attend Investor Conferences in August and September 2020

Read more ››
By: GlobenewsWire - 06 Aug 2020

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., Aug. 5, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:

Read more ››
By: PR Newswire Association LLC. - 06 Aug 2020
Related companies:  U.S. Food and Drug Administration

OPKO Health to Participate in BTIG Virtual Biotechnology Conference

Read more ››
By: GlobenewsWire - 05 Aug 2020
Related companies:  OPKO Health, Inc.

Immunomedics Reports Second Quarter 2020 Results and Provides Corporate Update

Read more ››
By: GlobenewsWire - 05 Aug 2020
Related companies:  Immunomedics, Inc.

Axogen, Inc. Reports Second Quarter 2020 Financial Results

Read more ››
By: GlobenewsWire - 05 Aug 2020
Related companies:  AxoGen, Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies